WallStreetZenWallStreetZen

NASDAQ: HBIO
Harvard Bioscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HBIO

Based on 1 analyst offering 12 month price targets for Harvard Bioscience Inc

Min Forecast
$7.50-5.66%
Avg Forecast
$7.50-5.66%
Max Forecast
$7.50-5.66%

Should I buy or sell HBIO stock?

Based on 1 analyst offering ratings for Harvard Bioscience Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HBIO stock forecasts and price targets.

HBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-12

1 of 1

Forecast return on equity

Is HBIO forecast to generate an efficient return?

Company
40.37%
Industry
17.87%
Market
133.67%
HBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HBIO forecast to generate an efficient return on assets?

Company
3.93%
Industry
12.9%
HBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HBIO earnings per share forecast

What is HBIO's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.39
Avg 2 year Forecast
$0.66

HBIO revenue forecast

What is HBIO's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$91.6M+4.31%
Avg 2 year Forecast
$96.7M+10.12%
HBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HBIO revenue growth forecast

How is HBIO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
4.31%
Industry
2.91%
Market
19.34%
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HBIO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HBIO$7.95$7.50-5.66%Buy
MLSS$0.41N/AN/A
NEPH$4.31N/AN/A
POCI$4.46N/AN/A
FEMY$2.59$10.00+286.10%Strong Buy
View Top Medical Stocks

Harvard Bioscience Stock Forecast FAQ

Is Harvard Bioscience Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HBIO) stock is to Buy HBIO stock.

Out of 1 analyst, 0 (0%) are recommending HBIO as a Strong Buy, 1 (100%) are recommending HBIO as a Buy, 0 (0%) are recommending HBIO as a Hold, 0 (0%) are recommending HBIO as a Sell, and 0 (0%) are recommending HBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.

What is HBIO's earnings growth forecast for 2026-2027?

(NASDAQ: HBIO) Harvard Bioscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 86.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,189.38%.

Harvard Bioscience's earnings in 2026 is -$10,412,000.On average, 4 Wall Street analysts forecast HBIO's earnings for 2026 to be -$1,764,473, with the lowest HBIO earnings forecast at -$2,765,981, and the highest HBIO earnings forecast at -$669,189.

In 2027, HBIO is forecast to generate $2,994,961 in earnings, with the lowest earnings forecast at $1,650,666 and the highest earnings forecast at $4,397,527.

What is HBIO's revenue growth forecast for 2026-2027?

(NASDAQ: HBIO) Harvard Bioscience's forecast annual revenue growth rate of 4.31% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 2.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.34%.

Harvard Bioscience's revenue in 2026 is $87,808,000.On average, 4 Wall Street analysts forecast HBIO's revenue for 2026 to be $416,972,929, with the lowest HBIO revenue forecast at $399,728,797, and the highest HBIO revenue forecast at $430,192,823.

In 2027, HBIO is forecast to generate $440,189,684 in revenue, with the lowest revenue forecast at $417,573,833 and the highest revenue forecast at $458,872,344.

What is HBIO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: HBIO) forecast ROA is 3.93%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.9%.

What is HBIO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HBIO price target, the average HBIO price target is $7.50, with the highest HBIO stock price forecast at $7.50 and the lowest HBIO stock price forecast at $7.50.

The Wall Street analyst predicted that Harvard Bioscience's share price could fall to $7.50 by Aug 12, 2027. The average Harvard Bioscience stock price prediction forecasts a potential downside of 5.66% from the current HBIO share price of $7.95.

What is HBIO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: HBIO) Harvard Bioscience's current Earnings Per Share (EPS) is -$2.31. On average, analysts forecast that HBIO's EPS will be -$0.39 for 2026, with the lowest EPS forecast at -$0.61, and the highest EPS forecast at -$0.15. In 2027, HBIO's EPS is forecast to hit $0.66 (min: $0.36, max: $0.97).

What is HBIO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: HBIO) forecast ROE is 40.37%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.